Apyx Medical (APYX) 10-Q 15 May 18 2018 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2018	May 09, 2018
Document And Entity Information
Entity Registrant Name	BOVIE MEDICAL CORP
Entity Central Index Key	719,135
Document Type	10-Q
Document Period End Date	Mar. 31, 2018
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		32,879,970
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2,018

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 8,701	$ 9,949
Restricted cash	660	719
Trade accounts receivable, net of allowance of $147 and $204	5,143	4,857
Inventories, net	6,709	6,526
Prepaid expenses and other current assets	522	496
Total current assets	21,735	22,547
Property and equipment, net	6,338	6,408
Brand name and trademark	1,510	1,510
Purchased technology and license rights, net	189	179
Goodwill	185	185
Deposits	91	92
Other assets	64	67
Total assets	30,112	30,988
Current liabilities:
Accounts payable	2,097	1,583
Accrued severance and related	948	1,242
Accrued payroll	198	447
Current portion of mortgage note payable	239	239
Accrued and other liabilities	2,212	2,462
Total current liabilities	5,694	5,973
Mortgage note payable, net of current portion	2,395	2,455
Note payable	140	140
Deferred tax liability	368	368
Derivative liabilities	46	20
Total liabilities	8,643	8,956
STOCKHOLDERS' EQUITY
Common stock, $0.001 par value; 75,000,000 shares authorized; 33,021,170 issued and 32,878,091 outstanding as of March 31, 2018 and December 31, 2017	33	33
Additional paid-in capital	50,867	50,495
Accumulated deficit	(29,431)	(28,496)
Total stockholders' equity	21,469	22,032
Total liabilities and stockholders' equity	$ 30,112	$ 30,988

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2018	Dec. 31, 2017
Stockholders' equity:
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	75,000,000	75,000,000
Common stock, shares issued (in shares)	33,021,170	33,021,170
Common stock, shares outstanding (in shares)	32,878,091	32,878,091

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Income Statement [Abstract]
Sales	$ 9,916	$ 8,389
Cost of sales	4,926	4,163
Gross profit	4,990	4,226
Other costs and expenses:
Research and development	562	709
Professional services	506	390
Salaries and related costs	2,116	2,460
Selling, general and administrative	2,670	2,404
Total other costs and expenses	5,854	5,963
Loss from operations	(864)	(1,737)
Interest expense, net	(34)	(31)
Change in fair value of derivative liabilities	(26)	88
Total other (loss) income, net	(60)	57
Loss before income taxes	(924)	(1,680)
Income tax expense	11	5
Net loss	$ (935)	$ (1,685)
Loss per share
Basic (in dollars per share)	$ (0.03)	$ (0.05)
Diluted (in dollars per share)	$ (0.03)	$ (0.06)
Weighted average number of shares outstanding - basic (in shares)	32,878	30,860
Weighted average number of shares outstanding - dilutive (in shares)	32,878	30,887

CONSOLIDATED STATEMENT OF CHANG

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Beginning balance, amount at Dec. 31, 2016	$ 26,223	$ 1	$ 31	$ 49,625	$ (23,434)
Beginning balance (in shares) at Dec. 31, 2016		976	30,860
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation	159			159
Net loss	(1,685)				(1,685)
Ending balance, amount at Mar. 31, 2017	24,697	$ 1	$ 31	49,784	(25,119)
Ending balance (in shares) at Mar. 31, 2017		976	30,860
Beginning balance, amount at Dec. 31, 2017	22,032	$ 0	$ 33	50,495	(28,496)
Beginning balance (in shares) at Dec. 31, 2017		0	32,878
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock based compensation	372			372
Net loss	(935)				(935)
Ending balance, amount at Mar. 31, 2018	$ 21,469	$ 0	$ 33	$ 50,867	$ (29,431)
Ending balance (in shares) at Mar. 31, 2018		0	32,878

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash flows from operating activities
Net loss	$ (935)	$ (1,685)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	199	178
Provision for inventory obsolescence	(47)	(24)
Stock based compensation	372	159
Change in fair value of derivative liabilities	26	(88)
Provision for allowance for doubtful accounts	(9)	(7)
Changes in current assets and liabilities:
Trade receivables	(277)	461
Prepaid expenses	(26)	(226)
Inventories	(136)	(1,240)
Deposits and other assets	4	(2)
Accounts payable	514	570
Accrued and other liabilities	(793)	(914)
Net cash used in operating activities	(1,108)	(2,818)
Cash flows from investing activities
Purchases of technology, property and equipment	(139)	(71)
Net cash used in investing activities	(139)	(71)
Cash flows from financing activities
Repayment of mortgage note payable	(60)	(59)
Net cash used in financing activities	(60)	(59)
Net change in cash, cash equivalents and restricted cash	(1,307)	(2,948)
Cash, cash equivalents and restricted cash, beginning of period	10,668	15,235
Cash, cash equivalents and restricted cash, end of period	9,361	12,287
Cash paid for:
Interest paid	$ 34	$ 31

BASIS OF PRESENTATION

BASIS OF PRESENTATION	3 Months Ended
	Mar. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	BASIS OF PRESENTATION Unless the context otherwise indicates, the terms “we,” “our,” “us,” “Bovie,” and similar terms refer to Bovie Medical Corporation and its consolidated subsidiaries. The accompanying unaudited consolidated financial statements have been prepared based upon SEC rules that permit reduced disclosure for interim periods. For a more complete discussion of significant accounting policies and certain other information, please refer to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2017 . These financial statements reflect all adjustments that are necessary for a fair presentation of results of operations and financial condition for the interim periods shown, including normal recurring accruals and other items. The results for the interim periods are not necessarily indicative of results for the full year.

RECENT ACCOUNTING PRONOUNCEMENT

RECENT ACCOUNTING PRONOUNCEMENTS	3 Months Ended
	Mar. 31, 2018
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
RECENT ACCOUNTING PRONOUNCEMENTS	RECENT ACCOUNTING PRONOUNCEMENTS In January 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment . The purpose of this ASU is to reduce the cost and complexity of evaluating goodwill for impairment. It eliminates the need for entities to calculate the implied fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if that reporting unit had been acquired in a business combination. Under this ASU, an entity will perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge is recognized for the amount by which the carrying value exceeds the reporting unit's fair value. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted, however we have chosen not to do so. The amendment is not expected to have a material impact on our financial condition or results of operations. ASU No. 2016-18, Restricted Cash Flows provides guidance on the presentation of restricted cash and restricted cash equivalents, which are now included with cash and cash equivalents when reconciling the beginning and ending cash amounts shown on the statements of cash flows. Using the retrospective transition method required under the standard, the Company has adjusted the presentation of its Condensed Consolidated Statements of Cash Flows for all periods presented. The adoption of ASU No. 2016-18 did not have any other impact on the Company’s Consolidated Financial Statements. The following table provides additional detail by financial statement line item of the ASU 2016-18 impact in our Consolidated Statement of Cash Flows for the three months ended March 31, 2018 and 2017 : (In thousands) As Reported (Pre-Adoption) ASU 2016-18 Reported (Post Adoption) Three Months Ended March 31, 2018 Cash, cash equivalents and restricted cash, beginning of period 9,949 719 10,668 Three Months Ended March 31, 2017 Net change in cash, cash equivalents and restricted cash (2,948 ) — (2,948 ) Cash, cash equivalents and restricted cash, beginning of period 14,456 779 15,235 Cash, cash equivalents and restricted cash, end of period 11,508 779 12,287 ASU No. 2014-09 (ASC 606), Revenue from Contracts with Customers became effective for us beginning with the first quarter of 2018, and adopted the new accounting standard using the modified retrospective transition approach. The modified retrospective transition approach recognized any changes from the beginning of the year of initial application through retained earnings with no restatement of comparative periods. We record revenue under ASC 606 at a single point in time, when control is transferred to the customer, which is consistent with past practice. We will continue to apply our current business processes, policies, systems and controls to support recognition and disclosure under the new standard. Based on the results of the evaluation, we have determined that the adoption of the new standard presents no material impact on our consolidated financial statements. Application of the transition requirements of the new standard did not have a material impact on opening retained earnings. No other new accounting pronouncement issued or effective during the fiscal year had or is expected to have a material impact on our consolidated financial statements or disclosures.

INVENTORIES

INVENTORIES	3 Months Ended
	Mar. 31, 2018
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES Inventories are stated at the lower of cost or market. Cost is determined on a first in, first out basis. Finished goods and work-in-process inventories include material, labor and overhead costs. Factory overhead costs are allocated to inventory manufactured in-house based upon labor hours. Inventories consisted of the following: (In thousands) March 31, December 31, Raw materials $ 5,229 $ 5,163 Finished goods 3,346 3,276 Gross inventories 8,575 8,439 Less: reserve for obsolescence (1,866 ) (1,913 ) Net inventories $ 6,709 $ 6,526

INTANGIBLE ASSETS

INTANGIBLE ASSETS	3 Months Ended
	Mar. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS	INTANGIBLE ASSETS Intangible assets consisted of the following: (In thousands) March 31, December 31, Brand name and trademark (life indefinite) $ 1,510 $ 1,510 Purchased technology (5-17 year lives) $ 1,550 $ 1,513 Less: accumulated amortization (1,361 ) (1,334 ) Purchased technology, net $ 189 $ 179 Goodwill $ 185 $ 185 With respect to our trademark and brand name, we continue to market products, release new products and product extensions and maintain and promote these trademarks and brand name in the marketplace through legal registration and such methods as advertising, medical education and trade shows. Based on our annual impairment testing, these trademarks and brand names will generate cash flow for an indefinite period of time. Therefore, we believe our trademarks and brand name intangible assets are not impaired. Goodwill results from our acquisition of Bovie Bulgaria, EOOD. Amortization of purchased technology was $27,000 for the three months ended March 31, 2018 and 2017 . Amortization expense is classified within selling, general and administration expenses in the consolidated statements of operations.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	3 Months Ended
	Mar. 31, 2018
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS Certain assets and liabilities that are measured at fair value on a recurring basis are measured in accordance with FASB ASC Topic 820-10-05, Fair Value Measurements . FASB ASC Topic 820-10-05 defines fair value, establishes a framework for measuring fair value and expands the disclosure requirements regarding fair value measurements for financial assets and liabilities as well as for non-financial assets and liabilities that are recognized or disclosed at fair value on a recurring basis in the financial statements. The statement requires fair value measurement be classified and disclosed in one of the following three categories: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity). Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to their fair value measurement. Our derivative financial instruments that are measured at fair value on a recurring basis are all measured at fair value using Level 3 inputs. Level 3 inputs are unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The following represents a reconciliation of the changes in fair value of warrants measured at fair value using Level 3 inputs during the three months ended March 31, 2018 : (in thousands) 2013 Placement Agent Warrants Balance, December 31, 2017 $ 20 Change in fair value 26 Balance, March 31, 2018 $ 46 The warrants are valued using a trinomial lattice model. Significant assumptions used in the model at March 31, 2018 included the market price of our common stock, an expected dividend yield of zero , the remaining life of 1.2 years , historical volatility of 68.754% and risk-free rates of return of 2.153% .

EARNINGS PER SHARE

EARNINGS PER SHARE	3 Months Ended
	Mar. 31, 2018
Earnings Per Share [Abstract]
EARNINGS PER SHARE	EARNINGS PER SHARE We compute basic earnings per share (“basic EPS”) by dividing the net income or loss by the weighted average number of common shares outstanding for the reporting period. Diluted earnings per share (“diluted EPS”) gives effect to all dilutive potential shares outstanding. The following table provides the computation of basic and diluted earnings per share. Three Months Ended (in thousands, except per share data) 2018 2017 Numerator: Net loss available to common shareholders $ (935 ) $ (1,685 ) Effect of dilutive securities: Derivative liability - warrants — (88 ) Numerator for dilutive loss per common share $ (935 ) $ (1,773 ) Denominator: Weighted average shares used to compute basic loss per common share 32,878 30,860 Effect of dilutive securities: Derivative liability - warrants — 27 Denominator for dilutive loss per common share 32,878 30,887 Basic loss per common share $ (0.03 ) $ (0.05 ) Diluted loss per common share $ (0.03 ) $ (0.06 )

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	3 Months Ended
	Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
STOCK-BASED COMPENSATION	STOCK-BASED COMPENSATION Under our stock option plans, our board of directors may grant options to purchase common shares to our key employees, officers, directors and consultants. We account for stock options in accordance with FASB ASC Topic 718, Compensation - Stock Compensation , with option expense amortized over the vesting period based on the trinomial lattice option-pricing model fair value on the grant date, which includes a number of estimates that affect the amount of our expense. We expensed approximately $372,000 in stock-based compensation during the three months ended March 31, 2018 , as compared with $159,000 for the three months ended March 31, 2017 . The status of our stock options and stock awards are summarized as follows: Number of options Weighted average exercise price Outstanding at December 31, 2017 4,860,157 $ 3.00 Granted 42,000 2.53 Outstanding at March 31, 2018 4,902,157 $ 2.98 Common shares required to be issued upon the exercise of stock options and warrants would be issued from our authorized and unissued shares. We calculated the fair value of issued options utilizing a trinomial lattice with an expected life calculated via the simplified method as we do not have sufficient history to determine actual expected life. 2018 Grants Option value $ 1.46 - $ 1.60 Risk-free rate 1.9% Expected dividend yield — Expected volatility 68.8% Expected term (in years) 6

INCOME TAXES

INCOME TAXES	3 Months Ended
	Mar. 31, 2018
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES The Company's income tax expense was $11,000 with an effective tax rate of 0.0% for the three months ended March 31, 2018 , as compared to $5,000 with an effective tax rate of 0.0% for the three months ended March 31, 2017 . The Company's effective tax rate differs from the statutory rate primarily due to the change in the valuation allowance on the Company's net deferred tax assets with a finite life. As a result of historical losses, the Company recorded a valuation allowance on the net deferred tax asset with a finite life and does not anticipate recording an income tax benefit related to these deferred tax assets. The Company will reassess the realization of deferred tax assets each reporting period and will be able to reduce the valuation allowance to the extent that the financial results of these operations improve and it becomes more likely than not that the deferred tax assets are realizable. For the three months ended March 31, 2018 , we do not believe we had any significant uncertain tax positions nor did we have any interest or penalties related to any significant uncertain tax positions. The Company is subject to U.S. federal income tax, state income tax and Bulgarian income tax. Until the respective statutes of limitations expire (which may be as much as 20 years while we have unused Net Operating Losses), we are subject to income tax audits in the jurisdictions in which we operate.

COMMITMENTS, CONTINGENCIES AND

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS	3 Months Ended
	Mar. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS	COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS Property and Rental Agreements In March 2014, we signed a lease for offices located in Purchase, New York. We decided to consolidate operations in the Purchase, NY office with the facility in Clearwater, Florida. Based on this, we determined the office in Purchase, NY was no longer necessary and decided to cease all activity at the location. The remaining lease was expensed in the fourth quarter of 2017 and included as part of severance and related expense, $147,000 will be operational cash outflows during 2018 and 2019. In October 2015, pursuant to our acquisition of Bovie Bulgaria, we are obligated to pay a lease of $6,300 per month, expiring in December 2021, for 18,745 square feet of office, research and manufacturing space in Sofia, Bulgaria. The following is a schedule of approximate future minimum lease payments under operating leases as of March 31, 2018 : (In thousands) 2018 (remaining nine months) $ 57 2019 76 2020 76 2021 76 Total $ 285 Litigation The medical device industry is characterized by frequent claims and litigation, and we are and may become subject to various claims, lawsuits and proceedings in the ordinary course of our business, including claims by current or former employees, distributors and competitors, and with respect to our products and product liability claims, lawsuits and proceedings. We are involved in a number of legal actions relating to the use of our J-Plasma technology. The outcomes of these legal actions are not within our complete control and may not be known for prolonged periods of time. In the opinion of management, the Company has meritorious defenses, and such claims are adequately covered by insurance, or are not expected, individually or in the aggregate, to result in a material, adverse effect on our financial condition. However, in the event that damages exceed the aggregate coverage limits of our policy or if our insurance carriers disclaim coverage, we believe it is possible that costs associated with these claims could have a material adverse impact on our consolidated earnings, financial position or cash flows. Purchase Commitments At March 31, 2018 , we had purchase commitments for inventories totaling approximately $5.4 million , substantially all of which is expected to be purchased by the end of 2018 . Concentrations Our ten largest customers accounted for approximately 27.8% and 46.2% of trade receivables as of March 31, 2018 and 2017 , respectively, and approximately 41.9% and 56.2% of net revenues for the three months ended March 31, 2018 and 2017 , respectively. For the three months ended March 31, 2018 , McKesson and National Distribution & Contracting Inc. accounted for 14.5% and 5.3% of sales, respectively, while for the same period in 2017 , McKesson and National Distribution & Contracting Inc. accounted for 16.0% and 8.7% of sales, respectively.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2018
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS Several relatives of Nikolay Shilev, Bovie Bulgaria’s Managing Director, are considered related parties. Teodora Shileva, Mr. Shilev’s spouse, is an employee of the Company working in the Accounting department. Antoaneta Dimitrova Shileva-Toromanova, Mr. Shilev’s sister, is the Manager of Production and Human Resources. Svetoslav Shilev, Mr. Shilev’s son, is an Engineer in the Quality Assurance department.

LONG TERM DEBT

LONG TERM DEBT	3 Months Ended
	Mar. 31, 2018
Debt Disclosure [Abstract]
LONG TERM DEBT	LONG TERM DEBT On June 28, 2016, the Company entered into a transaction with Bank of Tampa, a Florida banking corporation (“Lender”), wherein Lender amended the terms of a mortgage loan (“the Loan”) originally executed on March 20, 2014 with a principal amount of $3,592,000 . The Initial Maturity Date of the Loan was extended to July 20, 2019 from March 19, 2017, and the Extended Maturity Date was amended to July 20, 2024 from March 20, 2022. In addition, the Lender released as collateral to the Loan, the Company’s working capital accounts in exchange for a negative covenant limited to $2,000,000 of the aggregate indebtedness secured by these accounts. The obligations under the Loan are secured by a first mortgage and security interest in the Company’s Clearwater, Florida facility. In addition, the Company has pledged an interest in a certificate of deposit in the amount of $660,000 as additional collateral. The amount of the additional collateral required declines on a pro rata basis as principal is paid. Borrowings under the Loan bear interest at LIBOR plus 3.5% , with a fixed monthly principal payment of $19,956 . The interest rate at March 31, 2018 was 5.170% . The Loan documents contain customary financial covenants, including a covenant that the Company maintains a minimum liquidity, as defined, of $750,000 . Should we desire to extend the Loan beyond July 20, 2019, we must maintain a Debt Service Coverage Ratio for each of the preceding four quarters of not less than 1.0 to 1.0 . Our future contractual obligations for agreements with initial terms greater than one year are as follows: (In thousands) Long-term debt 2018 (remaining nine months) $ 239 2019 2,395 Total $ 2,634

GEOGRAPHIC AND SEGMENT INFORMAT

GEOGRAPHIC AND SEGMENT INFORMATION	3 Months Ended
	Mar. 31, 2018
Segment Reporting [Abstract]
GEOGRAPHIC AND SEGMENT INFORMATION	GEOGRAPHIC AND SEGMENT INFORMATION Operating segments are aggregated into reportable segments only if they exhibit similar economic characteristics. In addition to similar economic characteristics, we also consider the following factors in determining the reportable segments: the nature of business activities, the management structure directly accountable to our chief operating decision maker for operating and administrative activities, availability of discrete financial information and information presented to the Board of Directors and investors. Our reportable segments are disclosed as principally organized and managed as three operating segments: Core, OEM and Advanced Energy. We adopted reportable segments to align with changes in how we manage our business, review operating performance and allocate resources as a result of the growth in Advanced Energy and the differing behavior of the Core and OEM product lines. The Corporate & Other category includes certain unallocated corporate, operational, research and development and marketing costs which were not specifically attributed to any reportable segment. Net assets are shared, therefore, not allocated to the reportable segments. The OEM segment is primarily development contract and product driven, all related expenses are recorded as cost of sales, therefore no segment specific operating expenses are incurred. Summarized financial information with respect to reportable segments is as follows: Three Months Ended March 31, 2018 (In thousands) Core Advanced Energy OEM Corporate (Other) Total Sales $ 6,519 $ 2,629 $ 768 $ — $ 9,916 Income (loss) from operations 1,856 (578 ) 406 (2,548 ) (864 ) Interest expense, net — — — (34 ) (34 ) Change in fair value of derivative liabilities — — — (26 ) (26 ) Income tax expense — — — 11 11 Depreciation and amortization — — — 199 199 Three Months Ended March 31, 2017 (In thousands) Core Advanced Energy OEM Corporate (Other) Total Sales $ 6,775 $ 607 $ 1,007 $ — $ 8,389 Income (loss) from operations (1) 2,213 (1,819 ) 503 (2,634 ) (1,737 ) Interest expense, net — — — (31 ) (31 ) Change in fair value of derivative liabilities — — — 88 88 Income tax expense — — — 5 5 Depreciation and amortization — — — 178 178 (1) During the first quarter of 2017, marketing expenses were presented as attributable only to the Corporate (Other) segment in the line Income (loss) from operations. It was subsequently determined that certain marketing expenses are attributable to specific segments. The disclosure of Income (loss) from operations was updated for the first quarter of 2017 to reflect marketing expense by segment. International sales represented approximately 19.6% of total revenues for the three months ended March 31, 2018 , as compared with 16.7% of total revenues for the three months ended March 31, 2017 . Substantially all of these sales are denominated in U.S. dollars. Revenue by geographic region, based on the "ship to" location on the invoice are as follows: Three Months Ended (In thousands) 2018 2017 Sales by Domestic and International Domestic $ 7,973 $ 6,992 International 1,943 1,397 Total $ 9,916 $ 8,389

BASIS OF PRESENTATION (Policies

BASIS OF PRESENTATION (Policies)	3 Months Ended
	Mar. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Inventories	Inventories are stated at the lower of cost or market. Cost is determined on a first in, first out basis. Finished goods and work-in-process inventories include material, labor and overhead costs. Factory overhead costs are allocated to inventory manufactured in-house based upon labor hours.
Recent Accounting Pronouncements	In January 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment . The purpose of this ASU is to reduce the cost and complexity of evaluating goodwill for impairment. It eliminates the need for entities to calculate the implied fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if that reporting unit had been acquired in a business combination. Under this ASU, an entity will perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge is recognized for the amount by which the carrying value exceeds the reporting unit's fair value. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted, however we have chosen not to do so. The amendment is not expected to have a material impact on our financial condition or results of operations. ASU No. 2016-18, Restricted Cash Flows provides guidance on the presentation of restricted cash and restricted cash equivalents, which are now included with cash and cash equivalents when reconciling the beginning and ending cash amounts shown on the statements of cash flows. Using the retrospective transition method required under the standard, the Company has adjusted the presentation of its Condensed Consolidated Statements of Cash Flows for all periods presented. The adoption of ASU No. 2016-18 did not have any other impact on the Company’s Consolidated Financial Statements. The following table provides additional detail by financial statement line item of the ASU 2016-18 impact in our Consolidated Statement of Cash Flows for the three months ended March 31, 2018 and 2017 : (In thousands) As Reported (Pre-Adoption) ASU 2016-18 Reported (Post Adoption) Three Months Ended March 31, 2018 Cash, cash equivalents and restricted cash, beginning of period 9,949 719 10,668 Three Months Ended March 31, 2017 Net change in cash, cash equivalents and restricted cash (2,948 ) — (2,948 ) Cash, cash equivalents and restricted cash, beginning of period 14,456 779 15,235 Cash, cash equivalents and restricted cash, end of period 11,508 779 12,287 ASU No. 2014-09 (ASC 606), Revenue from Contracts with Customers became effective for us beginning with the first quarter of 2018, and adopted the new accounting standard using the modified retrospective transition approach. The modified retrospective transition approach recognized any changes from the beginning of the year of initial application through retained earnings with no restatement of comparative periods. We record revenue under ASC 606 at a single point in time, when control is transferred to the customer, which is consistent with past practice. We will continue to apply our current business processes, policies, systems and controls to support recognition and disclosure under the new standard. Based on the results of the evaluation, we have determined that the adoption of the new standard presents no material impact on our consolidated financial statements. Application of the transition requirements of the new standard did not have a material impact on opening retained earnings. No other new accounting pronouncement issued or effective during the fiscal year had or is expected to have a material impact on our consolidated financial statements or disclosures.
Fair Value Measurements	Certain assets and liabilities that are measured at fair value on a recurring basis are measured in accordance with FASB ASC Topic 820-10-05, Fair Value Measurements . FASB ASC Topic 820-10-05 defines fair value, establishes a framework for measuring fair value and expands the disclosure requirements regarding fair value measurements for financial assets and liabilities as well as for non-financial assets and liabilities that are recognized or disclosed at fair value on a recurring basis in the financial statements. The statement requires fair value measurement be classified and disclosed in one of the following three categories: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity). Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to their fair value measurement. Our derivative financial instruments that are measured at fair value on a recurring basis are all measured at fair value using Level 3 inputs. Level 3 inputs are unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

BASIS OF PRESENTATION BASIS OF

BASIS OF PRESENTATION BASIS OF PRESENTATION (Tables)	3 Months Ended
	Mar. 31, 2018
New Accounting Pronouncement, Early Adoption [Abstract]
New accounting pronouncement, early adoption	The following table provides additional detail by financial statement line item of the ASU 2016-18 impact in our Consolidated Statement of Cash Flows for the three months ended March 31, 2018 and 2017 : (In thousands) As Reported (Pre-Adoption) ASU 2016-18 Reported (Post Adoption) Three Months Ended March 31, 2018 Cash, cash equivalents and restricted cash, beginning of period 9,949 719 10,668 Three Months Ended March 31, 2017 Net change in cash, cash equivalents and restricted cash (2,948 ) — (2,948 ) Cash, cash equivalents and restricted cash, beginning of period 14,456 779 15,235 Cash, cash equivalents and restricted cash, end of period 11,508 779 12,287

INVENTORIES (Tables)

INVENTORIES (Tables)	3 Months Ended
	Mar. 31, 2018
Inventory Disclosure [Abstract]
Schedule of inventory	Inventories consisted of the following: (In thousands) March 31, December 31, Raw materials $ 5,229 $ 5,163 Finished goods 3,346 3,276 Gross inventories 8,575 8,439 Less: reserve for obsolescence (1,866 ) (1,913 ) Net inventories $ 6,709 $ 6,526

INTANGIBLE ASSETS (Tables)

INTANGIBLE ASSETS (Tables)	3 Months Ended
	Mar. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of intangible assets	Intangible assets consisted of the following: (In thousands) March 31, December 31, Brand name and trademark (life indefinite) $ 1,510 $ 1,510 Purchased technology (5-17 year lives) $ 1,550 $ 1,513 Less: accumulated amortization (1,361 ) (1,334 ) Purchased technology, net $ 189 $ 179 Goodwill $ 185 $ 185

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	3 Months Ended
	Mar. 31, 2018
Fair Value Disclosures [Abstract]
Reconciliation of changes in fair value of warrants	The following represents a reconciliation of the changes in fair value of warrants measured at fair value using Level 3 inputs during the three months ended March 31, 2018 : (in thousands) 2013 Placement Agent Warrants Balance, December 31, 2017 $ 20 Change in fair value 26 Balance, March 31, 2018 $ 46 The warrants are valued using a trinomial lattice model. Significant assumptions used in the model at March 31, 2018 included the market price of our common stock, an expected dividend yield of zero , the remaining life of 1.2 years , historical volatility of 68.754% and risk-free rates of return of 2.153% .

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	3 Months Ended
	Mar. 31, 2018
Earnings Per Share [Abstract]
Basic and diluted earnings per share	The following table provides the computation of basic and diluted earnings per share. Three Months Ended (in thousands, except per share data) 2018 2017 Numerator: Net loss available to common shareholders $ (935 ) $ (1,685 ) Effect of dilutive securities: Derivative liability - warrants — (88 ) Numerator for dilutive loss per common share $ (935 ) $ (1,773 ) Denominator: Weighted average shares used to compute basic loss per common share 32,878 30,860 Effect of dilutive securities: Derivative liability - warrants — 27 Denominator for dilutive loss per common share 32,878 30,887 Basic loss per common share $ (0.03 ) $ (0.05 ) Diluted loss per common share $ (0.03 ) $ (0.06 )

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	3 Months Ended
	Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Summary of stock options and stock awards	The status of our stock options and stock awards are summarized as follows: Number of options Weighted average exercise price Outstanding at December 31, 2017 4,860,157 $ 3.00 Granted 42,000 2.53 Outstanding at March 31, 2018 4,902,157 $ 2.98
Schedule of option fair value assumptions	2018 Grants Option value $ 1.46 - $ 1.60 Risk-free rate 1.9% Expected dividend yield — Expected volatility 68.8% Expected term (in years) 6

COMMITMENTS, CONTINGENCIES AN26

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS (Tables)	3 Months Ended
	Mar. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
Future minimum lease payments under operating leases	The following is a schedule of approximate future minimum lease payments under operating leases as of March 31, 2018 : (In thousands) 2018 (remaining nine months) $ 57 2019 76 2020 76 2021 76 Total $ 285

LONG TERM DEBT (Tables)

LONG TERM DEBT (Tables)	3 Months Ended
	Mar. 31, 2018
Debt Disclosure [Abstract]
Summary of long-term debt	Our future contractual obligations for agreements with initial terms greater than one year are as follows: (In thousands) Long-term debt 2018 (remaining nine months) $ 239 2019 2,395 Total $ 2,634

GEOGRAPHIC AND SEGMENT INFORM28

GEOGRAPHIC AND SEGMENT INFORMATION (Tables)	3 Months Ended
	Mar. 31, 2018
Segment Reporting [Abstract]
Schedule of reporting information by segment	Summarized financial information with respect to reportable segments is as follows: Three Months Ended March 31, 2018 (In thousands) Core Advanced Energy OEM Corporate (Other) Total Sales $ 6,519 $ 2,629 $ 768 $ — $ 9,916 Income (loss) from operations 1,856 (578 ) 406 (2,548 ) (864 ) Interest expense, net — — — (34 ) (34 ) Change in fair value of derivative liabilities — — — (26 ) (26 ) Income tax expense — — — 11 11 Depreciation and amortization — — — 199 199 Three Months Ended March 31, 2017 (In thousands) Core Advanced Energy OEM Corporate (Other) Total Sales $ 6,775 $ 607 $ 1,007 $ — $ 8,389 Income (loss) from operations (1) 2,213 (1,819 ) 503 (2,634 ) (1,737 ) Interest expense, net — — — (31 ) (31 ) Change in fair value of derivative liabilities — — — 88 88 Income tax expense — — — 5 5 Depreciation and amortization — — — 178 178 (1) During the first quarter of 2017, marketing expenses were presented as attributable only to the Corporate (Other) segment in the line Income (loss) from operations. It was subsequently determined that certain marketing expenses are attributable to specific segments. The disclosure of Income (loss) from operations was updated for the first quarter of 2017 to reflect marketing expense by segment.
Schedule of revenue by geographic area	Revenue by geographic region, based on the "ship to" location on the invoice are as follows: Three Months Ended (In thousands) 2018 2017 Sales by Domestic and International Domestic $ 7,973 $ 6,992 International 1,943 1,397 Total $ 9,916 $ 8,389

RECENT ACCOUNTING PRONOUNCEME29

RECENT ACCOUNTING PRONOUNCEMENTS BASIS OF PRESENTATION (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
New Accounting Pronouncement, Early Adoption [Line Items]
Net change in cash, cash equivalents and restricted cash	$ (1,307)	$ (2,948)
Cash, cash equivalents and restricted cash, beginning of period	10,668	15,235
Cash, cash equivalents and restricted cash, end of period	9,361	12,287
Adjustments for New Accounting Principle, Early Adoption [Member]
New Accounting Pronouncement, Early Adoption [Line Items]
Net change in cash, cash equivalents and restricted cash		0
Cash, cash equivalents and restricted cash, beginning of period	719	779
Cash, cash equivalents and restricted cash, end of period		779
Previously reported
New Accounting Pronouncement, Early Adoption [Line Items]
Net change in cash, cash equivalents and restricted cash		(2,948)
Cash, cash equivalents and restricted cash, beginning of period	$ 9,949	14,456
Cash, cash equivalents and restricted cash, end of period		$ 11,508

INVENTORIES (Details)

INVENTORIES (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Inventory Disclosure [Abstract]
Raw materials	$ 5,229	$ 5,163
Finished goods	3,346	3,276
Gross inventories	8,575	8,439
Less: reserve for obsolescence	(1,866)	(1,913)
Net inventories	$ 6,709	$ 6,526

INTANGIBLE ASSETS (Details)

INTANGIBLE ASSETS (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Dec. 31, 2017
Finite-Lived Intangible Assets [Line Items]
Purchased technology, net	$ 189		$ 179
Goodwill	185		185
Amortization of Intangible Assets	27	$ 27
Brand name and trademark (life indefinite)
Indefinite-lived Intangible Assets [Line Items]
Brand name and trademark	1,510		1,510
Purchased technology
Finite-Lived Intangible Assets [Line Items]
Purchased technology	1,550		1,513
Less: accumulated amortization	(1,361)		(1,334)
Purchased technology, net	$ 189		$ 179
Purchased technology | Minimum
Finite-Lived Intangible Assets [Line Items]
Intangible asset, useful life (in years)	5 years
Purchased technology | Maximum
Finite-Lived Intangible Assets [Line Items]
Intangible asset, useful life (in years)	17 years

FAIR VALUE MEASUREMENTS - RECON

FAIR VALUE MEASUREMENTS - RECONCILIATION OF CHANGES IN FAIR VALUE OF WARRANTS (Details) - Warrant - Placement Agent Warrant $ in Thousands	3 Months Ended
	Mar. 31, 2018USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 20
Change in fair value	26
Ending balance	$ 46

FAIR VALUE MEASUREMENTS - NARRA

FAIR VALUE MEASUREMENTS - NARRATIVE (Details) - Warrant	3 Months Ended
	Mar. 31, 2018
Class of Stock [Line Items]
Expected dividend rate (as a percent)	0.00%
Expected term (in years)	1 year 2 months
Expected volatility rate (as a percent)	68.754%
Risk free interest rate (as a percent)	2.153%

EARNINGS PER SHARE (Details)

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Numerator:
Net loss available to common shareholders	$ (935)	$ (1,685)
Derivative liability - warrants	0	(88)
Numerator for dilutive loss per common share	$ (935)	$ (1,773)
Denominator:
Weighted average shares used to compute basic loss per common share (in shares)	32,878	30,860
Derivative liability - warrants (in shares)	0	27
Denominator for diluted loss per common share (in shares)	32,878	30,887
Earnings Per Share, Basic and Diluted [Abstract]
Basic loss per common share (in dollars per share)	$ (0.03)	$ (0.05)
Diluted loss per common share (in dollars per share)	$ (0.03)	$ (0.06)

EARNINGS PER SHARE EARNINGS PER

EARNINGS PER SHARE EARNINGS PER SHARE - NARRATIVE (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Earnings Per Share [Abstract]
Antidilutive securities excluded from computation of loss per common share (in shares)	473
Derivative liability - warrants (in shares)	0	27
Derivative liability - warrants	$ 0	$ 88

STOCK-BASED COMPENSATION - NARR

STOCK-BASED COMPENSATION - NARRATIVE (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock based compensation	$ 372	$ 159

STOCK-BASED COMPENSATION - SUMM

STOCK-BASED COMPENSATION - SUMMARY OF STOCK OPTIONS (Details)	3 Months Ended
	Mar. 31, 2018$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding, beginning of period (in shares) | shares	4,860,157
Granted (in shares) | shares	42,000
Outstanding, end of period (in shares) | shares	4,902,157
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Outstanding, beginning of period (in dollars per share) | $ / shares	$ 3
Granted (in dollars per share) | $ / shares	2.53
Outstanding, end of period (in dollars per share) | $ / shares	$ 2.98

STOCK-BASED COMPENSATION - FAIR

STOCK-BASED COMPENSATION - FAIR VALUE ASSUMPTIONS (Details)	3 Months Ended
	Mar. 31, 2018$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free rate (as a percent)	1.90%
Expected dividend yield (as a percent)	0.00%
Expected volatility (as a percent)	68.80%
Expected term (in years)	6 years
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option value (in dollars per share)	$ 1.46
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option value (in dollars per share)	$ 1.60

INCOME TAXES - EFFECTIVE TAX RA

INCOME TAXES - EFFECTIVE TAX RATE (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Income Tax Disclosure [Abstract]
Income tax expense	$ 11	$ 5
Effective income tax rate, percent (as a percent)	0.00%	0.00%

COMMITMENTS, CONTINGENCIES AN40

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS - FUTURE MINIMUM LEASE PAYMENTS (Details) $ in Thousands	Mar. 31, 2018USD ($)
Future minimum lease payments under operating leases
2018 (remaining nine months)	$ 57
2,019	76
2,020	76
2,021	76
Total	$ 285

COMMITMENTS, CONTINGENCIES AN41

COMMITMENTS, CONTINGENCIES AND CONCENTRATIONS - NARRATIVE (Details)	3 Months Ended
	Mar. 31, 2018USD ($)	Mar. 31, 2017	Dec. 31, 2017USD ($)	Oct. 31, 2015USD ($)ft²
Other Commitments [Line Items]
Purchase commitments for inventories	$ 5,404,000
Accrued severance and related	948,000		$ 1,242,000
Purchase, NY
Other Commitments [Line Items]
Accrued severance and related	$ 147,000
Customer concentration risk | Trade receivable | 10 Largest Customers
Other Commitments [Line Items]
Concentration receivable risk (as a percent)	27.80%	46.20%
Customer concentration risk | Sales Revenue | 10 Largest Customers
Other Commitments [Line Items]
Concentration receivable risk (as a percent)	41.90%	56.20%
Customer concentration risk | Sales Revenue | McKesson
Other Commitments [Line Items]
Concentration receivable risk (as a percent)	14.50%	16.00%
Customer concentration risk | Sales Revenue | National Distribution & Contracting Inc.
Other Commitments [Line Items]
Concentration receivable risk (as a percent)	5.30%	8.70%
Sophia, Bulgaria
Other Commitments [Line Items]
Area of real estate property (in square feet) | ft²				18,745
Monthly cost of office space				$ 6,300

LONG TERM DEBT - NARRATIVE (Det

LONG TERM DEBT - NARRATIVE (Details) - Mortgages	Jun. 28, 2016USD ($)	Mar. 31, 2018USD ($)
Debt Instrument [Line Items]
Mortgage loan, principal amount	$ 3,592,000
Certificate of deposit, amount pledged as collateral		$ 660,000
Fixed monthly principal payment	19,956
Effective interest rate (as a percent)		5.17%
Debt covenant, minimum liquidity	$ 750,000
Debt service coverage ratio for preceding four quarters for extension of loan	1
London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	3.50%
Secured Debt
Debt Instrument [Line Items]
Maximum working capital accounts	$ 2,000,000

LONG TERM DEBT - FUTURE MATURIT

LONG TERM DEBT - FUTURE MATURITIES (Details) $ in Thousands	Mar. 31, 2018USD ($)
Long-term Debt, Fiscal Year Maturity [Abstract]
2018 (remaining nine months)	$ 239
2,019	2,395
Total long-term debt	$ 2,634

GEOGRAPHIC AND SEGMENT INFORM44

GEOGRAPHIC AND SEGMENT INFORMATION - REPORTABLE SEGMENT (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Segment Reporting Information [Line Items]
Sales	$ 9,916	$ 8,389
Income (loss) from operations	(864)	(1,737)
Interest expense, net	(34)	(31)
Change in fair value of derivative liabilities	(26)	88
Income tax expense	11	5
Depreciation and amortization	199	178
Operating Segments | Core
Segment Reporting Information [Line Items]
Sales	6,519	6,775
Income (loss) from operations	1,856	2,213	[1]
Interest expense, net	0	0
Change in fair value of derivative liabilities	0	0
Income tax expense	0	0
Depreciation and amortization	0	0
Operating Segments | Advanced Energy
Segment Reporting Information [Line Items]
Sales	2,629	607
Income (loss) from operations	(578)	(1,819)	[1]
Interest expense, net	0	0
Change in fair value of derivative liabilities	0	0
Income tax expense	0	0
Depreciation and amortization	0	0
Operating Segments | OEM
Segment Reporting Information [Line Items]
Sales	768	1,007
Income (loss) from operations	406	503	[1]
Interest expense, net	0	0
Change in fair value of derivative liabilities	0	0
Income tax expense	0	0
Depreciation and amortization	0	0
Corporate (Other)
Segment Reporting Information [Line Items]
Sales	0	0
Income (loss) from operations	(2,548)	(2,634)	[1]
Interest expense, net	(34)	(31)
Change in fair value of derivative liabilities	(26)	88
Income tax expense	11	5
Depreciation and amortization	$ 199	$ 178
[1]	(1) During the first quarter of 2017, marketing expenses were presented as attributable only to the Corporate (Other) segment in the line Income (loss) from operations. It was subsequently determined that certain marketing expenses are attributable to specific segments. The disclosure of Income (loss) from operations was updated for the first quarter of 2017 to reflect marketing expense by segment.

GEOGRAPHIC AND SEGMENT INFORM45

GEOGRAPHIC AND SEGMENT INFORMATION - GEOGRAPHIC (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Segment Reporting Information [Line Items]
Sales	$ 9,916	$ 8,389
Domestic
Segment Reporting Information [Line Items]
Sales	7,973	6,992
International
Segment Reporting Information [Line Items]
Sales	$ 1,943	$ 1,397

GEOGRAPHIC AND SEGMENT INFORM46

GEOGRAPHIC AND SEGMENT INFORMATION - NARRATIVE (Details) - segment	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Segment Reporting [Abstract]
Number of operating segments (in segments)	3
Geographic concentration risk | Sales Revenue | International customers
Concentration Risk [Line Items]
Concentration receivable risk (as a percent)	19.60%	16.70%